Clinical Trials Logo

IMT clinical trials

View clinical trials related to IMT.

Filter by:
  • None
  • Page 1

NCT ID: NCT05540054 Completed - Copd Clinical Trials

Inspiratory Muscle Training Efficiency Before Bronchoscopic Procedure

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effectiveness of inspiratory muscle training (IMT) before bronchoscopic procedure in Chronic Obstructive Pulmonary Patients (COPD). Patients with a diagnosis of COPD, who are listed for a bronchoscopic procedure and referred to the pulmonary rehabilitation (PR) clinic, will be randomly divided into two groups. Standard PR exercise program will be applied to both groups. In addition to the standard program, IMT will be applied to one of the groups. The effect of IMT on exercise program gains will be examined.

NCT ID: NCT05160922 Recruiting - NSCLC Clinical Trials

Crizotinib Continuation Clinical Study

Start date: December 27, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this continuation study is to provide continued access to crizotinib treatment for eligible participants from a current Pfizer sponsored crizotinib clinical study that is planned to close.

NCT ID: NCT02127333 Completed - Clinical trials for Endothelial Dysfunction

Role of Oxygen for Vascular Dysfunction

Start date: January 2011
Phase: N/A
Study type: Observational

Hypoxemia may contribute increased morbidity and mortality in chronic obstructive pulmonary disease (COPD) patients. We aim to characterize the role of acute and chronic hypoxemia for vascular function. For this purpose we measure capillary oxygen concentration and vascular. Vascular function is assessed by flow-mediated dilation oft he brachial artery, forearm blood flow and laser doppler perfusion imaging. We hypothesize that hypoxemia leads to impaired vascular function.

NCT ID: NCT01862146 Completed - Smoking Clinical Trials

Arterial Remodeling in Smokers

TCA
Start date: April 2013
Phase: N/A
Study type: Observational

Cigarette smoking is the most important modifiable cardiovascular risk factor leading to endothelial dysfunction and was suggested to impair arterial regeneration.The aim of the study was to investigate the effect of smoking on vascular response to transradial coronary angiography (TCA).